Drug recall · October 29, 2025
Cetirizine Hydrochloride Tablets USP 10 mg recall
Why: Tablet/Capsules Imprinted with Wrong ID
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50
- Lots / codes
Lot # PY925014, PY925013, Exp. 1/31/2028
- Quantity
- 13,440 bottles
- Company
- JB Chemicals and Pharmaceuticals Ltd, Mumbai
- Distribution
- U.S. Nationwide
- Initiated
- September 12, 2025 · Voluntary: Firm initiated
- Classified
- October 17, 2025
- Reported
- October 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cetirizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.